Protect Pharmace Stock Price, News & Analysis
Company Description
Protect Pharmace (OTC Link: PRTT) is a publicly traded integrated freight & logistics company in the Industrials sector. The company has a market capitalization of $28.8M.
PRTT stock has declined 96.1% over the past year. Shares last traded at $0.0550.
This page provides a comprehensive overview of PRTT stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Protect Pharmace (PRTT) stock last traded at $0.0550, down 7.27% from the previous close. Over the past 12 months, the stock has lost 96.1%. At a market capitalization of $28.8M, PRTT is classified as a micro-cap stock with approximately 57.5M shares outstanding.
Latest News
Protect Pharmace has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 5 with negative movement. Key topics include acquisition, management. View all PRTT news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Protect Pharmace (PRTT) currently stands at 15 shares, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 86%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Protect Pharmace (PRTT) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
PRTT Company Profile & Sector Positioning
Protect Pharmace (PRTT) operates in the Integrated Freight & Logistics industry within the broader Industrials sector and is listed on the OTC Link.
Investors comparing PRTT often look at related companies in the same sector, including Titanium Transpo (TTNMF), Parcelpal Logistics Inc (PTNYF), Fbr Limited (FBRKF), Pacific Green Technologies Inc (PGTK), and Cyberlux (CYBL). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate PRTT's relative position within its industry.